Skip to main content
. Author manuscript; available in PMC: 2012 Jul 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2011 Jul;57(Suppl 1):S34–S39. doi: 10.1097/QAI.0b013e3182208003

Figure 1. Flow chart of routine and enhanced follow-up in the Aconda ART program in Abidjan, Côte d’Ivoire.

Figure 1

Legend to Figure 1:

Lost to follow up before month 6: (i) last contact with study team <month-6; (ii) not dead or transferred out before month-6; (iii) no further information on vital status being obtained during the 6 following months (between month-6 and month-12), or dead or transferred out between month-6 and month-12 and date of death or date of transfer >6 months after date of last contact with study team.

Lost to follow up before month 18: (i) last contact with study team <month-18; (ii) not dead or transferred out between month-6 and month-18; (iii) no further information on vital status being obtained during the 6 following months (between month-18 and month-24), or dead or transferred out between month-18 and month-24 and date of death or date of transfer >6 months after date of last contact with study team.

ART: antiretroviral therapy; LTFU: lost to follow-up